July 13, 2009—Balfour Beatty Construction used a winning combination to achieve success on the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) Office Building: adopting a “do what is best for the project” mentality and maintaining a sense of urgency in the schedule. The result was considerable completion of construction three months early for the $93.7 million, 393,000-square-foot facility at the FDA campus in Silver Spring, Maryland. A formal dedication was held in May.
Throughout the project, Balfour Beatty provided the maximum level of service to its clients, the General Services Administration (GSA) and the FDA, notes the company.
“Balfour Beatty Construction is proud to have turned over this building to the GSA on-budget and ahead of schedule,” said David Laib, P.E., Balfour Beatty’s senior vice president who oversaw the project.
The six-story, concrete-framed project is built to progressive collapse specifications.
Balfour Beatty provided general construction services on the project. Other members of the CDRH project team included Tishman Construction Corp. of Maryland, construction manager; KlingStubbins in association with RTKL Associates, architecture and engineering designers; Dynalectric Company, electrical subcontractor; Pierce Associates, mechanical subcontractor; Miller & Long Company, concrete subcontractor; Tidewater Glazing, glass and glazing subcontractor; and Manganaro Midatlantic, drywall subcontractor.
The CDRH Office Building is the third project Balfour Beatty has completed since 2004 at the FDA’s Silver Spring campus. Balfour Beatty also built the $89.2 million, 573,261-square-foot Center for Drug Evaluation and Research Office Building, and the $42 million, 123,000-square-foot Central Shared Use Building, which houses administrative functions.
For more information, see the Web site.
